These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7647999)

  • 21. Evidence that chylomicron remnants and beta-VLDL are transported by the same receptor pathway in J774 murine macrophage-derived cells.
    Ellsworth JL; Cooper AD; Kraemer FB
    J Lipid Res; 1986 Oct; 27(10):1062-72. PubMed ID: 3025323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane binding sites for plasma lipoproteins on endosomes from rat liver.
    Jaeckle S; Brady SE; Havel RJ
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1880-4. PubMed ID: 2538819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
    Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE
    J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
    Ji ZS; Fazio S; Lee YL; Mahley RW
    J Biol Chem; 1994 Jan; 269(4):2764-72. PubMed ID: 8300609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The very low density lipoprotein (VLDL) receptor--a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues.
    Takahashi S; Sakai J; Fujino T; Miyamori I; Yamamoto TT
    Mol Cell Biochem; 2003 Jun; 248(1-2):121-7. PubMed ID: 12870663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N; Devaraj SN; Devaraj H
    Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins.
    Gotto AM
    Am J Cardiol; 1990 Sep; 66(6):20A-23A. PubMed ID: 2203246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans.
    Ji ZS; Sanan DA; Mahley RW
    J Lipid Res; 1995 Mar; 36(3):583-92. PubMed ID: 7539827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis.
    Barnard GF; Erickson SK; Cooper AD
    J Clin Invest; 1984 Jul; 74(1):173-84. PubMed ID: 6330173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro.
    Taira K; Bujo H; Hirayama S; Yamazaki H; Kanaki T; Takahashi K; Ishii I; Miida T; Schneider WJ; Saito Y
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1501-6. PubMed ID: 11557679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
    Tacken PJ; Beer FD; Vark LC; Havekes LM; Hofker MH; Willems Van Dijk K
    Biochem J; 2000 Apr; 347(Pt 2):357-61. PubMed ID: 10749663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein lipase compensates for the defective function of apo E variants in vitro by interacting with proteoglycans and lipoprotein receptors.
    Mann WA; Meyer N; Berg D; Greten H; Beisiegel U
    Atherosclerosis; 1999 Jul; 145(1):61-9. PubMed ID: 10428296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein lipase (EC 3.1.1.34) targeting of lipoproteins to receptors.
    Beisiegel U; Heeren J
    Proc Nutr Soc; 1997 Jul; 56(2):731-7. PubMed ID: 9264123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
    Grosskopf I; Baroukh N; Lee SJ; Kamari Y; Harats D; Rubin EM; Pennacchio LA; Cooper AD
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2573-9. PubMed ID: 16166565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor.
    Gianturco SH; Ramprasad MP; Song R; Li R; Brown ML; Bradley WA
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):968-76. PubMed ID: 9633939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight.
    Dallinga-Thie GM; Franssen R; Mooij HL; Visser ME; Hassing HC; Peelman F; Kastelein JJ; Péterfy M; Nieuwdorp M
    Atherosclerosis; 2010 Jul; 211(1):1-8. PubMed ID: 20117784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertriglyceridemia: lipoprotein receptors and atherosclerosis.
    Gianturco SH; Gotto AM; Bradley WA
    Adv Exp Med Biol; 1985; 183():47-71. PubMed ID: 4036704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular metabolism of triglyceride-rich lipoproteins: role of heparan sulfate, lipoprotein lipase and lipoprotein receptors.
    Sehayek E; Eisenberg S
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():110-2. PubMed ID: 8767482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.